Faculty profile

Claire Bombardier

ResearcherToronto General Research InstituteUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Claire Bombardier

Researcher

Toronto General Research Institute

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
23 publications in the last five years, latest in 2026.
Senior (last) author on 9 recent papers, a sign of leading a research group.
Principal investigator on 5 research grants (5 CIHR), most recently in 2012.
Supervisor on 2 trainee awards (2 CIHR), most recently in 2015.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

130

Publications

1,542

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Clinical Practice Guidelines Interdisciplinary Education Local Adaptation Pharmacologic Interventions Rheumatoid Arthritis

Latest papers

Improving outcomes of patients living with psoriatic arthritis: The Observational Best Practices Research Initiative (OBRI-PsA) registry: Rationale, Methodology and Preliminary Data of 18 Months Follow-up
PLoS ONE · 2026
COVID-19 in rheumatoid arthritis: prevalence, hospital admission, and risk of all-cause mortality before and after COVID-19 pandemic.
Clinical and experimental rheumatology · 2026
Treatment sequences and lines of therapy in rheumatoid arthritis: a real-world evaluation of retention and effectiveness.
Clinical and experimental rheumatology · 2026

All 130 publications

Latest funding

Personalizing the choice of therapy in rheumatoid arthritis
CIHR · 2021 · Co-investigator
$100,000
Personalizing the choice of therapy in rheumatoid arthritis
CIHR · 2021 · Co-investigator
$420,752
UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
CIHR · 2016 · Co-investigator
$4,967,500

All 15 grants and awards

130 publications.

Improving outcomes of patients living with psoriatic arthritis: The Observational Best Practices Research Initiative (OBRI-PsA) registry: Rationale, Methodology and Preliminary Data of 18 Months Follow-up

Attar RZ, Movahedi M, Cesta A, Li X, Sabido-Sauri R, Tsechelidis OB, Lau A, Chow A, Thorne C, Haaland D

PLoS ONE2026

DOI: 10.1371/journal.pone.0352264

COVID-19 in rheumatoid arthritis: prevalence, hospital admission, and risk of all-cause mortality before and after COVID-19 pandemic.

Movahedi M, Li X, Cesta A, Bombardier C, Hepworth E, Aydin SZ, OBRI investigators

Clinical and experimental rheumatology2026

DOI: 10.55563/clinexprheumatol/00jq99 PMID: 40892632

Treatment sequences and lines of therapy in rheumatoid arthritis: a real-world evaluation of retention and effectiveness.

Movahedi M, Kuriya B, Cesta A, Li X, Aydin SZ, Bombardier C, Akhavan P, Ontario Best Practices Initiative (OBRI) Investigators, UHN, Toronto, Canada.

Clinical and experimental rheumatology2026

DOI: 10.55563/clinexprheumatol/y1vbr1 PMID: 41231429

Healthcare utilization among patients with rheumatoid arthritis, with and without herpes zoster, a retrospective administrative data linked cohort study

Movahedi M, Cesta A, Li X, Tatangelo MR, Bombardier C, investigators OBOO

PLoS ONE20251 citationsSenior author

DOI: 10.1371/journal.pone.0323229

Retention of triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine compared to combination methotrexate and leflunomide in rheumatoid arthritis

Bhavsar SV, Movahedi M, Cesta A, Pope JE, Bombardier C, investigators OO

Joint Bone Spine20247 citationsSenior author

DOI: 10.1016/j.jbspin.2024.105732

Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2

Nikolic RPA, Pardo JP, Pope JE, Barber CEH, Barnabe C, Schieir O, Jamal S, Legge A, Kuriya B, Akhavan P

Journal of Rheumatology20243 citations

DOI: 10.3899/jrheum.2024-0540

Functional disability and disease activity are affected by social determinants of health in patients with rheumatoid arthritis.

Movahedi M, Cui K, Tomlinson G, Cesta A, Li X, Bombardier C

Clinical rheumatology2024Senior author

DOI: 10.1007/s10067-024-07148-3 PMID: 39365381

Impact of anti-rheumatic treatment on the individual components of the ACR composite score in patients with rheumatoid arthritis: real-world data.

Movahedi M, Choquette D, Coupal L, Keystone E, Bombardier C, Bessette L

Clinical and experimental rheumatology2024

DOI: 10.55563/clinexprheumatol/6qobnr PMID: 38855967

Biologics initiation in moderate versus severe rheumatoid arthritis: real-world experience from a Canadian registry.

Guo N, Li X, Movahedi M, Cesta A, Bombardier C

Clinical and experimental rheumatology2024Senior author

DOI: 10.55563/clinexprheumatol/mpevid PMID: 38372710

Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research Initiative.

Rampakakis E, Thorne C, Cesta A, Movahedi M, Li X, Mously C, Ahluwalia V, Brophy J, Ciaschini P, Keystone E

Clinical and Experimental Rheumatology202310 citationsSenior author

DOI: 10.55563/clinexprheumatol/b85xu5

Something wrong or missing on this profile? Suggest a correction

Claire Bombardier

Research

Latest papers

Latest funding

Improving outcomes of patients living with psoriatic arthritis: The Observational Best Practices Research Initiative (OBRI-PsA) registry: Rationale, Methodology and Preliminary Data of 18 Months Follow-up

COVID-19 in rheumatoid arthritis: prevalence, hospital admission, and risk of all-cause mortality before and after COVID-19 pandemic.

Treatment sequences and lines of therapy in rheumatoid arthritis: a real-world evaluation of retention and effectiveness.

Healthcare utilization among patients with rheumatoid arthritis, with and without herpes zoster, a retrospective administrative data linked cohort study

Retention of triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine compared to combination methotrexate and leflunomide in rheumatoid arthritis

Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2

Functional disability and disease activity are affected by social determinants of&#xa0;health in patients with rheumatoid arthritis.

Impact of anti-rheumatic treatment on the individual components of the ACR composite score in patients with rheumatoid arthritis: real-world data.

Biologics initiation in moderate versus severe rheumatoid arthritis: real-world experience from a Canadian registry.

Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research Initiative.

Frequent collaborators

Mohammad Movahedi

J Michael Paterson

George Tomlinson

Jessica Widdifield

Arthur Lau

Alfred Cividino

Carlo Ammendolia

Sankalp Bhavsar

Derek Allan Haaland

Margaret Larche

Karen Tu

Nader Khalidi

Manisha Mulgund

Saeed Shaikh

Raj Carmona

Mark Matsos

Andrew Chow

Sasha Bernatsky

Raja Bobba

Viktoria Pavlova

Sasha Bernatsky

Cheryl Barnabe

Jessica Widdifield

Gillian Hawker

Sanjay Dixit

Heather Boon

Noah Ivers

Paula Rochon

Noah Ivers

Paula Rochon

Carter Thorne

Peter Tugwell

David Moher

Vandana Ahluwalia

Diane Lacaille

Janet Pope

Murray Krahn

Deborah Marshall

Arnav Agarwal

Rajwinder Dhillon

Functional disability and disease activity are affected by social determinants of health in patients with rheumatoid arthritis.